New in vitro models to study amyotrophic lateral sclerosis

Brain Pathology

Volumn 26, Issue 2, 2016, Pages 258-265

  Myszczynska, Monika ^a   Ferraiuolo, Laura ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

astrocytes; cell models; iPSC; motor neurons

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; CELL REPROGRAMMING TECHNIQUE; CONFERENCE PAPER; DISEASE MODEL; EMBRYONIC STEM CELL; HUMAN; IN VITRO STUDY; MOUSE EMBRYONIC STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIMARY CELL CULTURE; ANIMAL; DRUG EFFECTS; GENETICS; INDUCED PLURIPOTENT STEM CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; PRECLINICAL STUDY; PROCEDURES;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELLULAR REPROGRAMMING TECHNIQUES; DRUG EVALUATION, PRECLINICAL; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS;

EID: 84961815155     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12353     Document Type: Conference Paper

References (68)

1. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, et al, (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26: 1276-1284.
2. Alami NH, Smith RB, Carrasco MA, Williams LA, Winborn CS, Han SSW, et al, (2014) Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 81: 536-543.
3. Al-Chalabi A, Jones A, Troakes C, King A, Al-Sarraj S, van den Berg LH., (2012) The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol 124: 339-352.
4. Almeida S, Gascon E, Tran H, Chou HJ, Gendron TF, Degroot S, et al, (2013) Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol 126: 385-399.
5. Alves CJ, Dariolli R, Jorge FM, Monteiro MR, Maximino JR, Martins RS, et al, (2015) Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration. Front Cell Neurosci 9: 289.
6. Andrews PW, Cavagnaro J, Cavanagro J, Deans R, Feigal E, Feigel E, et al, (2014) Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells. Nat Biotechnol 32: 724-726.
7. Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, et al, (2012) Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci USA 109: 5803-5808.
8. Burkhardt MF, Martinez FJ, Wright S, Ramos C, Volfson D, Mason M, et al, (2013) A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol Cell Neurosci 56: 355-364.
9. Donnelly CJ, Zhang P-W, Pham JT, Haeusler AR, Heusler AR, Mistry NA, et al, (2013) RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80: 415-428.
10. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, et al, (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321: 1218-1221.
11. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al, (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72: 245-256.
12. Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, et al, (2012) Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med 4: 145ra104.
13. van Es MA, van Vught PWJ, Blauw HM, Franke L, Saris CGJ, Van den Bosch L, et al, (2008) Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat Genet 40: 29-31.
14. Farg MA, Sundaramoorthy V, Sultana JM, Yang S, Atkinson RAK, Levina V, et al, (2014) C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum Mol Genet 23: 3579-3595.
15. Ferraiuolo L, (2014) The non-cell-autonomous component of ALS: new in vitro models and future challenges. Biochem Soc Trans 42: 1270-1274.
16. Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ, (2011) Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 7: 616-630.
17. Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ, et al, (2014) Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis. Neuron 81: 1009-1023.
18. Freibaum BD, Lu Y, Lopez-Gonzalez R, Kim NC, Almeida S, Lee K-H, et al, (2015) GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525: 129-133.
19. Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M, (2009) Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85: 348-362.
20. Geser F, Robinson JL, Malunda JA, Xie SX, Clark CM, Kwong LK, et al, (2010) Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch Neurol 67: 1238-1250.
21. Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K, (2007) Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 10: 608-614.
22. Di Giorgio FP, Boulting GL, Bobrowicz S, Eggan KC, (2008) Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3: 637-648.
23. Haidet-Phillips AM, Hester ME, Meyer K, Braun L, Frakes A, et al, (2011) Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 29: 824-828.
24. Haidet-Phillips AM, Gross SK, Williams T, Miranda CJ, Tuteja A, Sherman A, Ko M, et al, (2013) Altered astrocytic expression of TDP-43 does not influence motor neuron survival. Exp Neurol 250C: 250-9.
25. Ilieva H, Polymenidou M, Cleveland DW, (2009) Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 187: 761-772.
26. Isobe T, Tooi N, Nakatsuji N, Aiba K, (2015) Amyotrophic lateral sclerosis models derived from human embryonic stem cells with different superoxide dismutase 1 mutations exhibit differential drug responses. Stem Cell Res 15: 459-468.
27. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande VC, et al, (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40: 572-574.
28. Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, Ostrow LW, et al, (2013) Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci 16: 571-579.
29. Karumbayaram S, Kelly TK, Paucar AA, Roe AJT, Umbach JA, Charles A, et al, (2015) Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS. Dis Model Mech 2: 189-195.
30. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, et al, (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323: 1205-1208.
31. Maherali N, Hochedlinger K, (2008) Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3: 595-605.
32. Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, Hochedlinger K, (2008) A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3: 340-345.
33. Marchetto MCN, Muotri AR, Mu Y, Smith AM, Cezar GG, Gage FH, (2008) Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3: 649-57.
34. Mertens J, Paquola ACM, Ku M, Hatch E, Böhnke L, Ladjevardi S, et al, (2015) Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects. Cell Stem Cell 17: 705-718.
35. Meyer K, Ferraiuolo L, Miranda CJ, Likhite S, McElroy S, Renusch S, et al, (2014) Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc Natl Acad Sci USA 111: 829-832.
36. Mitne-Neto M, Machado-Costa M, Marchetto MCN, Bengtson MH, Joazeiro CA, Tsuda H, et al, (2011) Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum Mol Genet 20: 3642-3652.
37. Miyoshi N, Ishii H, Nagano H, Haraguchi N, Dewi DL, Kano Y, et al, (2011) Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8: 633-638.
38. Nagai M, Re DB, Nagata T, Chalazonitis A, Chalazonitis A, Jessell TM, Wichterle H, et al, (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10: 615-622.
39. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al, (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130-133.
40. Nishimura AL, Mitne-Neto M, Silva HCA, Richieri-Costa A, Middleton S, Cascio D, et al, (2004) A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 75: 822-831.
41. Numasawa-Kuroiwa Y, Okada Y, Shibata S, Kishi N, Akamatsu W, Shoji M, et al, (2014) Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes. Stem Cell Reports 2: 648-661.
42. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S, (2008) Generation of mouse induced pluripotent stem cells without viral vectors. Science 322: 949-953.
43. Osafune K, Caron L, Borowiak M, Martinez RJ, Fitz-Gerald CS, Sato Y, et al, (2008) Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol 26: 313-315.
44. Ovchinnikov DA, Wolvetang EJ, (2014) Opportunities and limitations of modelling Alzheimer's disease with induced pluripotent stem cells. J Clin Med 3: 1357-1372.
45. Re DB, Le Verche V, Yu C, Amoroso MW, Politi KA, Phani S, et al, (2014) Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron 81: 1001-1008.
46. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al, (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72: 257-268.
47. Rojas F, Cortes N, Abarzua S, Dyrda A, van Zundert B, (2014) Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress. Front Cell Neurosci 8: 24.
48. Roybon L, Lamas NJ, Garcia-Diaz A, Yang EJ, Sattler R, Jackson-Lewis V, et al, (2013) Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes. Cell Rep 4: 1035-1048.
49. Sareen D, O'Rourke JG, Meera P, Muhammad AKMG, Grant S, Simpkinson M, et al, (2013) Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med 5: 208ra149.
50. Serio A, Bilican B, Barmada SJ, Ando DM, Zhao C, Siller R, et al, (2013) Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc Natl Acad Sci USA 110: 4697-4702.
51. Son EY, Ichida JK, Wainger BJ, Toma JS, Rafuse VF, Woolf CJ, et al, (2011) Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell 9: 205-218.
52. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al, (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319: 1668-1672.
53. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
54. Takahashi K, Okita K, Nakagawa M, Yamanaka S, (2007) Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2: 3081-3089.
55. Taura D, Noguchi M, Sone M, Hosoda K, Mori E, Okada Y, et al, (2009) Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS Lett 583: 1029-1033.
56. Thatava T, Kudva YC, Edukulla R, Squillace K, De Lamo JG, Khan YK, et al, (2013) Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Mol Ther 21: 228-239.
57. Toma JS, Shettar BC, Chipman PH, Pinto DM, Borowska JP, Ichida JK, et al, (2015) Motoneurons derived from induced pluripotent stem cells develop mature phenotypes typical of endogenous spinal motoneurons. J Neurosci 35: 1291-1306.
58. Torrent R, De Angelis RF, Dell'Era P, Memo M, Raya A, Consiglio A, (2015) Using iPS cells toward the understanding of Parkinson's disease. J Clin Med 4: 548-566.
59. Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al, (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323: 1208-1211.
60. Wainger BJ, Kiskinis E, Mellin C, Wiskow O, Han SSW, Sandoe J, et al, (2014) Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep 7: 1-11.
61. Wang S, Bates J, Li X, Schanz S, Chandler-Militello D, Levine C, et al, (2013) Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 12: 252-264.
62. Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, et al, (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11: 251-253.
63. Yang YM, Gupta SK, Kim KJ, Powers BE, Cerqueira A, Wainger BJ, et al, (2013) A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell 12: 713-26.
64. Yao X-L, Ye C-H, Liu Q, Wan J, Zhen J, Xiang AP, et al, (2013) Motoneuron differentiation of induced pluripotent stem cells from SOD1G93A mice. PLoS One 8: e64720.
65. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al, (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
66. Zhang K, Donnelly CJ, Haeusler AR, Grima JC, Machamer JB, Steinwald P, et al, (2015) The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525: 56-61.
67. Zhou W, Freed CR, (2009) Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27: 2667-2674.
68. Zhou T, Benda C, Dunzinger S, Huang Y, Ho JC, Yang J, et al, (2012) Generation of human induced pluripotent stem cells from urine samples. Nat Protoc 7: 2080-2089.